The longterm treatment of an asthmatic patient using phentolamine.
D000284:Administration, Oral; D001249:Asthma / Q000188:drug therapy* / Q000503:physiopathology; D001285:Atropine / Q000627:therapeutic use; D001794:Blood Pressure; D001986:Bronchial Spasm / Q000139:chemically induced; D001993:Bronchodilator Agents / Q000627:therapeutic use*; D002744:Chlorpheniramine / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D004205:Cromolyn Sodium / Q000627:therapeutic use; D004562:Electrocardiography; D004809:Ephedrine / Q000627:therapeutic use; D004837:Epinephrine / Q000009:adverse effects; D005260:Female; D006801:Humans; D007545:Isoproterenol / Q000009:adverse effects; D008875:Middle Aged; D010646:Phentolamine / Q000008:administration & dosage / Q000627:therapeutic use*; D005082:Physical Exertion; D010919:Placebos; D010993:Plethysmography, Whole Body; D011241:Prednisone / Q000627:therapeutic use; D013147:Spirometry; D013997:Time Factors; D014970:Xanthines / Q000627:therapeutic use
D001993:Bronchodilator Agents; D010919:Placebos; D014970:Xanthines; D002744:Chlorpheniramine; D001285:Atropine; D004809:Ephedrine; D007545:Isoproterenol; D004205:Cromolyn Sodium; D011241:Prednisone; D004837:Epinephrine; D010646:Phentolamine